U.S. gas prices reached $4 per gallon amid a surge in crude oil prices driven by the U.S.-Iran conflict, pushing major stock indexes toward their worst monthly and quarterly losses since 2022. Despite the spike in oil prices, Federal Reserve Chair Jerome Powell reassured investors that inflation remains stable and no immediate interest rate hikes are expected. Meanwhile, companies like Opendoor and Novo Nordisk are adapting to market changes with strategic moves in real estate tech and pharmaceutical subscriptions. JetBlue and other businesses are passing higher fuel costs to consumers, signaling broader economic impacts if geopolitical tensions persist.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
Vivani Medical is developing a semaglutide implant aimed at improving long-term adherence to GLP-1 treatments like Wegovy and Ozempic, which help with obesity and diabetes. The implant, designed to be replaced biannually or annually, could reduce sid...
